These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 5136470)
41. [Acute arrest of the retinal circulation eliminated by intravenous administration of Complamin]. Thomalske G; Manz R Med Klin; 1967 Jan; 62(3):98 passim. PubMed ID: 6031752 [No Abstract] [Full Text] [Related]
42. [Treatment of peripheral arterial insufficiency with inositol nicotinate (Hexanicit)]. Hentzer E Nord Med; 1966 Sep; 76(38):1090-3. PubMed ID: 5918550 [No Abstract] [Full Text] [Related]
43. [Modification of the vascular changes of the ocular fundus by xantinol nicotinate]. von Grósz I; Födö V Med Welt; 1969 Aug; 35():1916-7. PubMed ID: 5809867 [No Abstract] [Full Text] [Related]
45. [Specific range of action of a new gerontotherapeutic agent. Psychopharmacological and therapeutic study]. Oswald WD; Zeus L Med Welt; 1969 Jun; 25():1439-44. PubMed ID: 4978450 [No Abstract] [Full Text] [Related]
46. [A new product acting on cerebral circulation: results of the use in neurosurgery of 7-(2 hydroxy-3-N-2-hydroxy-ethyl-N-methylamino propyl) 1-3 dimethylaxanthine pyridine-3-carboxyl or complamin]. Pouyanne H; Guérin J; Maurin P J Med Bord; 1967 Nov; 114(11):1693-702. PubMed ID: 5602594 [No Abstract] [Full Text] [Related]
47. [Mental effects of Wallerox therapy in the aged]. Thomae H Med Klin; 1970 Jun; 65(23):1132-4. PubMed ID: 5000216 [No Abstract] [Full Text] [Related]
48. Tetranicotinoylfructose in disorders of digital blood flow. Holti G; Newell DJ; Poole HG Practitioner; 1971 Nov; 207(241):654-8. PubMed ID: 4944129 [No Abstract] [Full Text] [Related]
49. [On the treatment of cerebral and peripheral vascular disorders in general practice]. Glashoff E Ther Ggw; 1969 Jan; 108(1):88-95. PubMed ID: 5763821 [No Abstract] [Full Text] [Related]
50. [Clinical and practical experiences with Progresin, a magnesium containing vasoactive drug, in cerebral and peripheral blood circulation disorders]. Bode H; Bode W; Schnittler W Med Welt; 1971 Jun; 22(25):1044-51. PubMed ID: 5089363 [No Abstract] [Full Text] [Related]
51. [Clinical experience with Complamine in vascular diseases of the fundus oculi]. Fronimopoulos J; Cofinas H; Lambrou N Klin Monbl Augenheilkd; 1967; 151(2):201-7. PubMed ID: 5592110 [No Abstract] [Full Text] [Related]
52. [Therapeutic correction of senile behavior characteristics with Wallerox. Contribution on experimental psychological geriatrics]. Oswald WD; Müller-Egloff P; Becker E; Wilde M Munch Med Wochenschr; 1969 Jun; 111(26):1444-8. PubMed ID: 4980146 [No Abstract] [Full Text] [Related]
53. [Ambulatory treatment of cerebrovascular disorders including encephalographic and ophthalmologic studies]. Leube H; Schwaeppe C Med Monatsschr; 1970 Aug; 24(8):366-9. PubMed ID: 5515138 [No Abstract] [Full Text] [Related]
55. [Clinical study of the cerebrovascular action of pentoxifylline]. Shtok VN; Fedorova NV; Gadanova IV Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(1):60-6. PubMed ID: 7064607 [TBL] [Abstract][Full Text] [Related]
56. [On prolonged hemokinetic therapy of occlusive arterial diseases]. Alegría A Med Klin; 1965 Jul; 60(28):1126-31. PubMed ID: 5835983 [No Abstract] [Full Text] [Related]
57. [Pharmacological properties and clinical use of xanthinol nicotinate]. Mashkovskiĭ MD; Iuzhakov SD; Absava GI; Erokhina LG; Lebedeva NV Klin Med (Mosk); 1984 Nov; 62(11):30-4. PubMed ID: 6097742 [No Abstract] [Full Text] [Related]